Hilde Windels Director Share Options Holdings in MDxHealth SA

This Form 3 filing reports the beneficial ownership of share options by Hilde Windels, a director of MDxHealth SA. The filing discloses four separate share option grants held indirectly through Hilde Windels BV, where Windels serves as Managing Director. The options include: 1,000 ordinary shares at €49.70 per share granted June 1, 2018 expiring June 1, 2028; 1,000 ordinary shares at €12.80 per share granted July 1, 2019 expiring July 1, 2029; 30,000 ordinary shares at $2.62 per share granted June 22, 2024 expiring June 22, 2034; and 10,000 ordinary shares at $2.18 per share granted June 27, 2025 expiring June 27, 2035. All options have vested in full, with the first three vesting on the date of the annual general shareholders' meeting following the grant year, and the 2025 grant vesting on the same basis. Windels disclaims beneficial ownership of securities held by Hilde Windels BV except to the extent of her pecuniary interest.